Clinical Scenario

Thromboangiitis obliterans (Buerger's disease) requires prompt, structured first-line intervention. Management centres on a critical modifiable driver of disease activity, supported by a strategy to prevent secondary vascular events.

Treatment Approach (partial)

The first-line protocol addresses a key modifiable risk factor as its primary intervention, alongside secondary event prevention. The complete sequenced regimen — including full criteria and clinical decision points — is available via the link below.

Clinical Goal

The target outcome is disease remission of thromboangiitis obliterans. When the modifiable driver is fully eliminated, the disease can go into remission and limb amputation can be avoided.

References

DOI: 10.1155/2013/156905

The most effective treatment for Buerger's disease is smoking cessation.
All possible means should be used to encourage patients to give up the use of tobacco, in all its forms.
Aspirin is effective in preventing secondary events and should be considered in all patients with PAD.
Psychological help may be useful in certain cases, but patients should be reassured that if they manage to give up smoking completely, the disease will go into remission and amputation can be avoided.

View source ↗

What Is the First-Line Treatment of Thromboangiitis Obliterans?

References